Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CFSAN Priorities: Industry & Consumer Groups Weigh In On NDIs And More

Sep 11 2006

• By Rebekah Moan

Related Content

Supplement GMPs, NDI Guidance Should Top CFSAN 2007 Priority List – CRN

Aug 28 2006

FDA Gets Green Light For Risk-Benefit Analysis From Ephedra Ruling

Aug 21 2006

AER Bill Will Provide Documented History Of Supplement Safety – Industry

Jul 17 2006

Dietary Supplement, Functional Food Regulatory Harmonization Urged By GAO

Jul 17 2000

FDA Guidance Clarifies Labeling For Supplements Containing Food Allergens

Oct 24 2005

Supplement GMPs Received By OMB For 90-Day Clearance Review

Oct 31 2005

FDA Accomplishes A-List Goals, Will Publish NDI Guidance – CFSAN

Aug 22 2005

Additional Topics

OTC Drugs Consumer

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window